Career growth doesn’t just happen—you have to speak up for it. Many professionals work hard and deliver results, yet still get passed over for promotions, visibility, or stretch opportunities. This webinar helps you take control of your career by showing you what effective self-advocacy really looks like, why it matters, and how to do it with confidence—without feeling awkward or “pushy.”

Learn how to identify and overcome the common barriers that keep women from advocating for themselves, clearly articulate your value and impact, and communicate your career goals in a way that resonates with decision-makers. We'll cover how to navigate conversations about promotions, raises, expanded scope, and new opportunities, while also building visibility and sponsorship in a sustainable way. Whether you’re aiming for a promotion, greater leadership visibility, expanded responsibilities, or a career pivot, you’ll leave with a clear, personalized approach to advocating for yourself.

Disclaimer: This event may be recorded. If so, your image and/or voice may be a part of that recording. If you do not wish for your image to be included, please turn off your camera.

Speaker Bios

Katherine Andersen, Head of US Life Science & Healthcare at HSBC Innovation Banking

Katherine brings over two decades of experience in finance and innovation to her role as Head of US Life Science & Healthcare at HSBC Innovation Banking, which she joined in 2023 to help launch HSBC’s global platform serving the innovation economy. Previously, she led Life Science & Healthcare at SVB from 2015 to 2023, following leadership roles at Wells Fargo, Merrill Lynch, and GE Capital. With deep expertise across banking and capital markets, Katherine supports high-growth companies from Series A onward with tailored financial solutions. She holds degrees in economics and finance from Virginia Tech and has completed executive programs at Dartmouth, Harvard Law School, and GE. Based in Boston since 2006, Katherine is also an active community leader. She serves on the American Cancer Society’s CEOs Against Cancer team and the Board of Advisors for Life Science Cares.

Sarah Odeh, Vice President, Medical Affairs at TGaS Advisors

Sarah Odeh is a Partner and the Head of Medical Affairs at Trinity Life Sciences. She has nearly 20 years of experience in driving the development and execution of Medical Affairs strategies and launch plans atboth large and emerging life science companies, across a wide array of therapeutic areas. She is knownfor inspiring commercialization teams to deliver results that bring products to market in a patient-centric way. Sarah has a track record of developing high-impact strategic plans, executing company visions, and working cross-functionally to align medical objectives with overall business goals. At Trinity and TGaS, Sarah leads the Medical Affairs COE and Benchmarking team, providing clients with strategic advisory and benchmarking information to enable evidence-based decision-making. Before joining
Trinity, Sarah founded her own consulting company designed to support pharmaceutical and biotech companies with pre-commercialization activities, including establishing Medical Affairs infrastructure, and leading strategic medical planning and execution of tactical goals to ensure successful product launches. She also oversaw Medical Affairs Strategy for the cardiovascular pipeline at MyoKardia/BMS and led the global Medical Affairs activities at Aquinox Pharmaceuticals. Sarah has a degree in biochemistry from the University of Illinois, Urbana-Champaign, and was the 2024 National President of Women In Bio. She now serves on the Women In Bio Board of Directors. Previously, Sarah served as the Young Women In Bio (YWIB)-National Chair and as the YWIB-San Francisco Bay Area Committee.

Barbara Troupin, MD, MBA, Moderator

Barbara is a fractional Chief Medical and Strategy Officer working for several early-stage biotech, therapeutics and digital health companies. She works to guide teams on portfolio strategy, clinical development, regulatory planning and engagement, fundraising, and company growth. She also sits as an Independent Director on the Board of Equillium Bio (NASDAQ: EQ), and ProSciento, a private-equity backed CRO, and has been particularly interested in Board governance as a means to uplevel Board performance. Over her 20+ years as a life science executive, her roles have spanned Clinical, Medical, Regulatory, Operations and Strategy functional areas, working in both private and public companies. She holds an MD from the University of Pennsylvania and an MBA from the Wharton School of Business. She is broadly curious; an avid connector and values relationships where mutual learning and growth occur.
 

Pricing Information

• Members: Free
• Non-Members*: $15

*Not a Member? Click here to purchase a WIB membership and gain access to our video library, mentorship opportunities, and more. 

Please read WIB's Code of Conduct and Refund Policy.

Note: The Zoom link will be sent along with a confirmation email after registration has been completed.